Cite
Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals
MLA
Jackson Sembera, et al. “Sustained Spike-Specific IgG Antibodies Following CoronaVac (Sinovac) Vaccination in Sub-Saharan Africa, but Increased Breakthrough Infections in Baseline Spike-Naive Individuals.” Frontiers in Immunology, vol. 14, Nov. 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1255676.
APA
Jackson Sembera, Claire Baine, Violet Ankunda, Joseph Ssebwana Katende, Gerald Kevin Oluka, Christine Hermilia Akoli, Laban Kato, Geoffrey Odoch, Peter Ejou, Solomon Opio, Monica Musenero, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, & Jennifer Serwanga. (2023). Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1255676
Chicago
Jackson Sembera, Claire Baine, Violet Ankunda, Joseph Ssebwana Katende, Gerald Kevin Oluka, Christine Hermilia Akoli, Laban Kato, et al. 2023. “Sustained Spike-Specific IgG Antibodies Following CoronaVac (Sinovac) Vaccination in Sub-Saharan Africa, but Increased Breakthrough Infections in Baseline Spike-Naive Individuals.” Frontiers in Immunology 14 (November). doi:10.3389/fimmu.2023.1255676.